Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can a smart sensor beat finger sticks for diabetes control?

NCT ID NCT05944432

Ongoing Disease control Sponsor: Abbott Diabetes Care Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study compares continuous glucose monitoring using the FreeStyle Libre 3 sensor to standard finger-stick testing in 470 adults with type 2 diabetes whose blood sugar is not well controlled. Participants continue their usual medications (basal insulin plus SGLT2 inhibitor and/or GLP-1). The main goal is to see if the sensor improves HbA1c levels over 16 weeks. This is a management study, not a cure, as diabetes requires ongoing care.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DIABETES MELLITUS, TYPE 2 are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

type 2 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

DIABETES MELLITUS, TYPE 2

Contacts and locations

Locations

  • Cambridge University Hospital (Addenbrookes)

    Cambridge, United Kingdom

  • Churchill Hospital

    Oxford, United Kingdom

  • Darlington Memorial Hospital

    Darlington, United Kingdom

  • Derriford Hospital

    Plymouth, United Kingdom

  • Hull Royal Infirmary

    Hull, United Kingdom

  • Ipswich Hospital

    Ipswich, United Kingdom

  • King's College Hospital

    London, United Kingdom

  • Leicester General Hospital

    Leicester, United Kingdom

  • Manchester Royal Infirmary

    Manchester, M13 9WU, United Kingdom

  • Moorgreen Hospital

    Southampton, United Kingdom

  • Ninewells Hospital

    Dundee, United Kingdom

  • Norfolk and Norwich University Hospital

    Norwich, United Kingdom

  • Northern General Hospital

    Sheffield, United Kingdom

  • Northwick Park Hospital

    Harrow, United Kingdom

  • Princess Alexandra Hospital

    Harlow, United Kingdom

  • Queen Alexandra Hospital

    Portsmouth, United Kingdom

  • Queen Elizabeth Hospital

    Birmingham, United Kingdom

  • Royal Derby Hospital

    Derby, DE22 3NE, United Kingdom

  • Royal United Hospital

    Bath, United Kingdom

  • Singleton Hospital

    Swansea, United Kingdom

  • St James University Hospital

    Leeds, United Kingdom

  • St Mary's Hospital

    London, United Kingdom

  • Tameside General Hospital

    Ashton-under-Lyne, United Kingdom

  • The Adam Practice

    Poole, United Kingdom

  • Wishaw Hospital

    Wishaw, United Kingdom

More trials for these conditions

Other studies related to the condition(s) this trial covers.